High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation

2.50
Hdl Handle:
http://hdl.handle.net/10547/578858
Title:
High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation
Authors:
Liberante, Fabio G.; Pellagatti, Andrea; Boncheva, Viktoriya Bogdanova; Bowen, David T.; Mills, Ken I.; Boultwood, Jacqueline; Guinn, Barbara-Ann
Citation:
Liberante, F.G., Pellagatti, A., Boncheva, V., Bowen, D.T., Mills, K.I., Boultwood, J. & Guinn, B.A. (2013) 'High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation' British Journal of Haematology. 162 (2) pp 282-284.
Publisher:
Wiley
Journal:
British Journal of Haematology
Issue Date:
Jul-2013
URI:
http://hdl.handle.net/10547/578858
DOI:
10.1111/bjh.12352
Additional Links:
http://doi.wiley.com/10.1111/bjh.12352
Type:
Article
Language:
en
ISSN:
0007-1048
Sponsors:
This work was supported in part by Wessex Medical Research and a Wellcome Value In People award (BG), Northern Ireland Leukaemia Research Fund (NILRF) and the NI Department of Education and Learning (FL) and Leukaemia and Lymphoma Research (AP and JB).
Appears in Collections:
Biomedicine and Nutrition Research Group

Full metadata record

DC FieldValue Language
dc.contributor.authorLiberante, Fabio G.en
dc.contributor.authorPellagatti, Andreaen
dc.contributor.authorBoncheva, Viktoriya Bogdanovaen
dc.contributor.authorBowen, David T.en
dc.contributor.authorMills, Ken I.en
dc.contributor.authorBoultwood, Jacquelineen
dc.contributor.authorGuinn, Barbara-Annen
dc.date.accessioned2015-09-29T08:37:32Zen
dc.date.available2015-09-29T08:37:32Zen
dc.date.issued2013-07en
dc.identifier.citationLiberante, F.G., Pellagatti, A., Boncheva, V., Bowen, D.T., Mills, K.I., Boultwood, J. & Guinn, B.A. (2013) 'High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation' British Journal of Haematology. 162 (2) pp 282-284.en
dc.identifier.issn0007-1048en
dc.identifier.doi10.1111/bjh.12352en
dc.identifier.urihttp://hdl.handle.net/10547/578858en
dc.description.sponsorshipThis work was supported in part by Wessex Medical Research and a Wellcome Value In People award (BG), Northern Ireland Leukaemia Research Fund (NILRF) and the NI Department of Education and Learning (FL) and Leukaemia and Lymphoma Research (AP and JB).en
dc.language.isoenen
dc.publisherWileyen
dc.relation.urlhttp://doi.wiley.com/10.1111/bjh.12352en
dc.rightsArchived with thanks to British Journal of Haematologyen
dc.subjectmyelodysplastic syndromeen
dc.subjecttumour antigensen
dc.subjectPreferentially expressed Antigen of the Melanoma Geneen
dc.subjectleukaemia antigensen
dc.subjectsurvivalen
dc.titleHigh and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentationen
dc.typeArticleen
dc.identifier.journalBritish Journal of Haematologyen
dc.contributor.institutionCentre for Cancer Research and Cell Biology; Queens University Belfast; Belfast; UKen
dc.contributor.institutionLeukaemia and Lymphoma Research Molecular Haematology Unit; Nuffield Department of Clinical Laboratory Sciences; John Radcliffe Hospital; Oxford; UKen
dc.contributor.institutionDepartment of Life Sciences; University of Bedfordshire; Luton; UKen
dc.contributor.institutionLeeds Teaching Hospitals NHS Trust; Leeds; UKen
dc.contributor.institutionCentre for Cancer Research and Cell Biology; Queens University Belfast; Belfast; UKen
dc.contributor.institutionLeukaemia and Lymphoma Research Molecular Haematology Unit; Nuffield Department of Clinical Laboratory Sciences; John Radcliffe Hospital; Oxford; UKen
All Items in UOBREP are protected by copyright, with all rights reserved, unless otherwise indicated.